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Objective: Human immunodeficiency virus (HIV) prevention efficacy trials with psychiatric patients
have been conducted in research settings in high-resourced countries, establishing short-term efficacy
for reducing sexual risk behavior. None has been implemented within systems of care. In the last
decade, overcoming this research-to-practice gap has become a focus of implementation science.
This paper describes the first and only HIV Prevention intervention trial for psychiatric patients
conducted in real-world outpatient psychiatric settings facilitated by trained clinic-based providers.
Methods: The HIV Prevention intervention, which uses the Information-Motivation-Behavioral
Skills model to achieve sexual risk-reduction, was rigorously adapted to the local context and
clinic services’ needs. Participants from eight clinics were randomized to HIV Prevention or Health
Promotion conditions.
Results: HIV Prevention participants showed significant improvement in Information-Motivation-
Behavioral domains; in this group, behavioral intentions were associated with significantly fewer
unprotected sex occasions, but reduction of unprotected sex occasions was similar in both conditions.
Conclusion: Our trial was conducted before implementation studies became widely funded.
Transporting an intervention to a new culture or into real-world practice settings may require
adaptations. Our results demonstrate that clear guidelines are needed regarding whether to conduct
efficacy, effectiveness, and/or implementation research as the most appropriate next step.
Clinical trial registration: NCT00881699
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Introduction
Worldwide, human immunodeficiency virus (HIV) infection
rates among people with severe mental illness (SMI)
are much higher than the general population.1 Global
initiatives that strive to end the HIV epidemic must include
this vulnerable population.2 More than 30 risk behavior
studies, conducted primarily in the United States, have
shown that, compared to the general population, adults
with psychiatric illness have higher rates of sexual absti-
nence, but when sexually active, they have higher rates of
many risk activities, including having multiple sex part-
ners, having sex partners with known HIV risk behav-
iors, exchanging sex for money, shelter or goods, using
condoms infrequently, having sex partners of unknown or
positive HIV status, and sex between men.
HIV Prevention interventions have focused on reducing
these prevalent sexual risk behaviors in this popula-
tion. Efficacious interventions all incorporate aspects or
principles of behavior change derived from testable
models of risk-reduction – predominantly the Information-
Motivation-Behavioral Skills (IMB) model – and use
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multiple-session, small group delivery formats. The IMB
model posits that three fundamental components are
required to reduce HIV-related sexual risk behaviors: 1)
information regarding the routes of HIV infection/trans-
mission and methods of risk-reduction/prevention; 2)
motivation to reduce HIV risk behaviors (e.g., condom
use attitudes, intentions) by acting on existing knowledge;
and 3) behavioral skills (e.g., technical skills in condom
use and sexual assertiveness/negotiation).3 Studies have
shown that the IMB model is appropriate to the needs of
adults with SMI who have misinformation about how
HIV is transmitted and reduced self-efficacy4; compo-
nents of the model have been shown to predict sexual risk
behavior changes over time.5
When the present study began, six intervention trials
provided evidence of the feasibility and efficacy of HIV-
sexual-risk-reduction interventions tailored to people with
SMI; these studies were conducted in the United States
by researchers outside clinical settings. The results showed
increases in HIV-related knowledge, positive attitudes
toward condom use, increased intentions to reduce risk
behaviors, increased condom use self-efficacy, and reduc-
tions in risk behaviors from 3 to 6 months post-interven-
tion that diminished over time.4,6-11 Limitations included
relatively small samples, single-gender samples, lack of
attention-control conditions, variability in measures of risk
behavior, look-back periods, follow-up intervals and defini-
tions of efficacy, small effect sizes, and testing of the
interventions in research sites rather than clinical settings.
This paper describes the first and only sexual risk-reduction
intervention trial for people with mental illness to be con-
ducted in outpatient psychiatric programs facilitated by
trained clinic-based providers.
Brazil’s robust response to the HIV epidemic has
served as a model for HIV prevention and treatment
policies around the world, making Brazil an ideal site to
adapt and test efficacious U.S. HIV Prevention interven-
tions for psychiatric patients.12 We obtained U.S. National
Institute of Mental Health (NIMH) funding to conduct
two consecutive studies in Rio de Janeiro, RJ, Brazil
(R01MH065163; principal investigator [PI] MLW, both
studies). These studies (PRojeto Interdisciplinar em
Sexualidade, Saúde Mental e AIDS, or Interdisciplinary
Project on Sexuality, Mental Health and AIDS – PRISSMA)
were conducted before implementation science was a
NIMH funding priority. PRISSMA 1 involved adapting the
six efficacious U.S. interventions into one intervention that
was culturally tailored and piloted within the public mental
health system in Rio de Janeiro.13-15 This paper reports on
PRISSMA 2, a randomized controlled trial (RCT) con-
ducted in real-world clinics and facilitated by clinic
providers to reduce sexual risk.16 Both PRISSMA studies
were consistent with current calls to adapt interventions in
a manner that enhances the likelihood of successful
implementation in new settings.14
Methods
For context, we briefly describe PRISSMA 1, a multi-
component, 4-year study that used: community-based
participatory research14; simultaneous training of
Brazilian and U.S. investigators in research methodology;
ethnographic observations, focus group discussions, and
key informant interviews with psychiatric patients and
mental health care providers; translation of the extant
published U.S. efficacious risk-reduction interventions4,7,8
into Portuguese and adaption of the interventions to local
culture and clinic services’ needs; translation of relevant
Brazilian materials into English so that the U.S. research
team could learn local theoretical approaches and
message delivery strategies; translation and adaption of
assessment instruments2 plus training of local research
staff to administer them; and community participation in
the adaptation and implementation of the intervention
through recruitment of a diverse and representative com-
munity advisory board (Figure 1).
All stakeholders focused on balancing fidelity to the
efficacious interventions and fit to the new setting (both a
new culture, Brazil, and a new setting, public outpatient
psychiatric clinics). Culturally-based modifications to
delivery strategies included considering the impact of
cultural beliefs and mental illness stigma on sexual risk
behaviors, incorporating interactive and expressive activ-
ities, considering low literacy rates, and determining that
mixed-gender groups would fit best into clinic activities
and reinforce safer peer norms in a predominantly hetero-
sexual patient population. An attention-control interven-
tion manual used in a previous U.S. RCT addressing
common comorbid medical conditions was translated
and adapted to specific local needs. Details of these
approaches can be found elsewhere.8
The resulting interventions (HIV Prevention and Health
Promotion) were manualized, pre-piloted with adult psy-
chiatric patients in one of the psychiatric clinics, and
finalized after incorporating all feedback. Assessments
were pre-piloted and refined for use in the pilot phase. We
conducted the feasibility pilot at a different psychiatric
clinic to prevent contamination from the pre-pilot. Rando-
mization to intervention conditions was carried out suc-
cessfully. Baseline data demonstrated high rates of
sexual risk behavior among sexually active participants.
At 3 months post-intervention, there was a reduction in
the mean number of unprotected acts among sexually
active participants in the HIV Prevention group and a
corresponding increase in the Health Promotion group.
Thus, the results were in the desired direction, although
the pilot study was not designed to test efficacy.15 There
were no adverse events. Quality control demonstrated
good to very good facilitator adherence and competence.
Two-thirds of the participants attended five or more of
the eight sessions, with 94% reporting being very satisfied
with the intervention. The feasibility of conducting a two-
arm trial was established.
The current study (PRojeto Interdisciplinar em
Sexualidade, Saúde Mental e AIDS, or Interdisciplinary
Project on Sexuality, Mental Health and AIDS –
PRISSMA 2)
When applying for funding for this RCT, we followed the
NIMH and the National Advisory Mental Health Council
standards which, at that time, called for efficacy testing
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when adapting evidence-based interventions for new
settings rather than using either effectiveness or nascent
implementation designs. The resulting large, multisite
RCT was the first such trial to evaluate the efficacy of U.S.
HIV risk-reduction interventions adapted for adult psy-
chiatric patients in a lower-resourced country and embo-
died five innovations, being: 1) adapted from existing
efficacious interventions using a community-based parti-
cipatory research approach; 2) clinician-delivered; 3)
conducted within public mental health settings; 4) adapted
to and conducted in a lower-resourced country; and
5) designed to establish long-term (12-month post-
intervention) outcomes. We tested the hypothesis that
the HIV Prevention condition would reduce sexual risk
significantly more from baseline to 12 months post-
intervention than an attention-matched Health Promotion
control condition.
Participants
Participants were recruited from four community mental
health clinics and four hospital-based outpatient mental
health clinics; in Brazil, these are the most common types
of clinics in which public mental health care is delivered.
Patients whose primary psychiatric diagnosis is an alcohol
or other drug use disorder are treated in designated
specialized settings. Flyers and posters were distributed
in the clinics. Clinic providers were informed about the
study and asked to refer all patients to the study recruiters,
who screened all provider- and self-referred patients for
eligibility. Our community advisory board included one
clinician and a relative of one patient from each of the eight
RCT clinic sites and advised the research team every
2-3 months. Given the high percentage of participants with
sexual risk behaviors in our sexually active pilot sample
(78%), the community advisory board urged us to include
all sexually active patients having vaginal and/or anal
intercourse, whether protected or not, in the 3 months prior
to enrollment. There were two ethical reasons for this:
1) concern that patients might engage in risk behavior for
the purpose of becoming eligible to participate in the study
(even in the absence of reimbursement for participation,
which was not permitted in Brazil); and 2) concern that
sexually active low-risk patients might not remain so.
The consensus reached was that no sexually active patient
should be denied the potential benefit of participation.
Eligible participants were at least 18 years old, sexually
active (vaginal and/or anal sex) in the prior 3 months
regardless of condom use, receiving psychiatric treatment
in the study sites, and capable of giving written informed
consent. Patients with primary alcohol or other drug use
disorder and/or intellectual disabilities were not eligible to
participate, and those with acute psychosis or active
suicidality at the time of the screening interview also were
excluded unless eligible upon reassessment once they
were stable. Although the existing U.S.-based efficacious
interventions were developed for psychiatric patients with
diagnoses consistent with SMI, this trial was conducted
in clinical rather than research settings and was not restric-
ted to those with SMI; instead, patients meeting study
eligibility criteria also included those with common mental
disorders (e.g., depression, anxiety, post-traumatic stress
disorder, etc.).
Procedures
After eligibility screening, evaluation of capacity to
consent, obtaining written informed consent, and baseline
assessments (see Measures), qualified participants were
randomized in each cohort by gender in a 1:1 ratio within
Figure 1 Overview of PRISSMA studies. PRISSMA = PRojeto Interdisciplinar em Sexualidade, Saúde Mental e AIDS
(Interdisciplinary Project on Sexuality, Mental Health and AIDS); RCT = randomized clinical trial.
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each clinic, blind to condition, using procedures to ensure
unbiased randomization into the HIV Prevention interven-
tion or the attention-matched Health Promotion control
intervention, which focused on chronic medical conditions
commonly seen in psychiatric populations and included
the provision of HIV information as one of the topics. Both
intervention conditions comprised eight 2-hour group
sessions that took place weekly in each clinic and three
booster sessions delivered 6 months after the completion
of the initial eight sessions. Participants in both study
arms received the same assessments on the same
schedule: immediately post-intervention; 3- and 6-months
post-intervention; immediately post-booster (7-months
post-intervention); and 12-months post-intervention
(about 15 months post-baseline assessment). Assess-
ment at all timepoints included the primary outcome:
sexual risk behaviors during the past 3 months. Psychia-
tric diagnosis was assessed at baseline. Participants
were provided with transportation and food vouchers
valued at $10 per visit. The U.S.-Brazil research team
conducted training of recruiters and interviewers, weekly
supervision, review of recorded sessions, and inter-rater
reliability evaluation of the diagnostic and risk behavior
assessments. Trained mental health professionals, blind
to the participants’ intervention condition assignment,
carried out all assessments through face-to-face inter-
views. The interviews were audiotaped, and every
seventh tape was reviewed for quality assurance. Each
group session in both intervention conditions was co-led
by two facilitators: usually of different genders, from a
range of disciplines (e.g., psychologists; social workers;
occupational, music, and art therapists; nurses), and from
within the system of care. Experienced supervisors
trained recruited staff in group facilitation using the
manualized interventions. Two different teams of facil-
itators conducted the experimental and control interven-
tions to minimize bias and/or contamination between
intervention conditions. We video-recorded the interven-
tion and booster sessions and tracked attendance.
Supervision included corrective feedback and observation
of sessions.
Measures
To test the hypothesis that the HIV Prevention inter-
vention would reduce sexual risk significantly more
from baseline to 12 months post-intervention than the
attention-matched control Health Promotion interven-
tion, we measured sexual risk behavior and participant
characteristics.
Demographic and clinical characteristics
Participants were asked their age, gender, sexual orien-
tation, race/ethnicity, marital status, and education level.
The Mini-International Neuropsychiatric Interview-PLUS,
a structured psychiatric interview validated for the DSM-
IV and ICD-10 with both U.S. English and Brazilian
Portuguese-speaking patients, was used to assess both
severe and common mental disorders.17
Sexual risk behavior
The primary outcome measure, self-reported frequency
of unprotected vaginal and/or anal sex occasions during
the last 3 months, was assessed using the Sexual Risk
Behavior Assessment Schedule (SERBAS), which has
undergone extensive psychometric testing with a variety
of populations, including people in psychiatric care in
Brazil.18 Consistent with previous SMI reliability studies in
the United States, The Brazilian version of SERBAS
showed excellent test-retest reliability for being sexually
active in the past 3 months (kappa = 1.0), and fair to good
agreement on the frequency of anal and vaginal sex,
including unprotected occasions (intraclass correlation =
0.5-1.0).15,18
The SERBAS employs gender-specific interviews to
elicit detailed information regarding sexual practices and
related behaviors in the past 3 months, including the
number, gender, and type of sex partner (steady, casual,
or exchange); the types of sexual acts performed during
each sex occasion; whether sexual acts were protected by
condoms (male or female); whether sex was preceded by
substance use (e.g., alcohol/drugs); whether sex was
bought or sold (e.g., exchange sex); and the participant’s
self-reported history of HIV testing and status and knowl-
edge of his/her partner(s)’ HIV testing history and status.19
Intervention model measures
The measures also included rigorously-translated and
back-translated instruments examining the IMB model
intervention components.3 HIV knowledge about trans-
mission and prevention was assessed using the Brief HIV
Knowledge Questionnaire, an 18-item true/false scale
that has been used with SMI populations in the US.20 The
translation and back-translation resulted in the elimination
of one item due to confusing double-negative phrasing in
Portuguese. Thus, scores range from 0 to 17, with higher
scores indicating greater knowledge. The questionnaire
has acceptable internal consistency (= 0.75-0.89), and
test-retest reliability (= 0.76-0.94).15,20
Motivation for behavior change was assessed by three
measures. Behavioral intentions regarding HIV were
measured with four items that assess strength of
intentions to reduce HIV risk behavior (e.g., ‘‘I will use a
condom the next time I have sex’’). Items are scored on a
four-point Likert scale (1 = ‘‘definitely will not do’’ to 4 =
‘‘definitely will do’’); higher scores indicate greater inten-
tions to act to reduce risk.21 Two items from the access to
condoms measure were used to assess whether partici-
pants had condoms either with them or in their homes.
Both measures have been used in prior research
(average alpha = 0.8221), including with SMI populations.
The Condom Attitude Scale consists of 10 items that
assess participants’ attitudes toward condom use on a
four-point Likert scale (1 = ‘‘strongly disagree’’ to 4 =
‘‘strongly agree’’; range 10 to 40), with higher scores
representing more positive attitudes toward condom use.8
Behavioral skills were assessed through the Condom
Self-Efficacy Scale, which consists of eight items that
measure perceived self-efficacy or confidence in using a
Braz J Psychiatry. 2020;42(4)
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condom in risk-related situations in five domains (condom
confidence, condom discussion, partner resistance, reg-
ular/new partner, and impulse control). The items are
scored on a four-point Likert scale (1 = ‘‘very unsure’’ to
4 = ‘‘very sure’’; range 8-32), with higher scores indicating
greater self-efficacy.19
Intervention
The goals of the experimental intervention were to: 1)
increase information about HIV risk behaviors and safer sex
options; 2) increase identification of personal risk for HIV
and enhance motivation to engage in safer sex behaviors;
and 3) enhance skills to achieve safer sex, particularly
negotiating safer sex, using condoms, and good commu-
nication in relationships. Each session had ‘‘homework’’
assignments to be reviewed in the following sessions that
aimed at increasing knowledge and motivation and practi-
cing skills. Interactive exercises in the sessions reinforced
the prevention principles that mediate the intervention.
The attention-control intervention focused on common
chronic medical conditions that are comorbid with psy-
chiatric illness (e.g., diabetes, hypertension), or condi-
tions common to the local context (e.g., malnutrition,
tuberculosis). We chose the control intervention during
the ethnographic phase of our first study by asking clinic
patients about their unmet service needs; their providers
and our Brazilian partners ratified this choice. The control
intervention also had interactive exercises and ‘‘home-
work’’ assignments.
Data analysis
We aimed to achieve 90% statistical power to detect an
effect size corresponding to a difference of 6.9 unpro-
tected sex occasions (with standard deviation [SD] of 17
sex occasions) between the two groups.7 This effect size
derived from Study 1. A total of 255 participants would be
required to achieve 90% power for testing the primary
hypothesis with a type I error rate a = 0.05, two-tailed.
There were three other considerations in the sample size
calculation: participant attrition, cross-condition contam-
ination, and variance inflation due to clustering (as the
intervention sessions were provided in groups). We
anticipated no more than 20% attrition and assumed that
approximately 5% of the control participants would be
exposed to the active intervention through peer interac-
tion and 5% in the active intervention would fail to receive
it. Further, an intraclass correlation coefficient no greater
than 0.02 for an average cluster size of 10 meant
recruiting a total of 448 participants (224 per group) to
adjust for the above three factors. Because we planned to
impute for the missing data in our primary analysis, the
actual study power might be greater than 90%. Descrip-
tive statistics were generated for the total sample and
according to intervention group for demographic variables
at baseline and 12 months. The a priori primary analysis,
following intent-to-treat principles, compared the inter-
vention participants to the control participants in terms of
change from baseline to 12-months post-intervention in
total number of vaginal and anal intercourse occasions
not protected by condoms. We used generalized linear
models with log link function.22 The model included the
group indicator for intervention participants (vs. control),
the indicator for time (12-month follow-up vs. baseline),
and the interaction of the two indicators. The regression
coefficient corresponding to the group-by-time interaction
term estimated the logarithm of the ratio of the two study
group population rate ratios (i.e., the ratio of the mean
number of vaginal and/or anal intercourse occasions
unprotected by condoms at 12 months vs. baseline), and
thus represents the effect of the intervention on change in
unprotected sex occasions. We used generalized esti-
mating equations to account for the effect of intracluster
correlations introduced by multiple assessments on the
same participant.23 An over-dispersion parameter was
used to account for the between-subject heterogeneity.
Rubin’s24,25 multiple imputation method with 11 repeated
imputations was used to impute the missing endpoint for
the intention-to-treat analysis.
In secondary analyses, we evaluated intervention effects
on major secondary outcomes (i.e., those measuring IMB),
which included HIV knowledge, behavioral intentions,
condom attitudes, and self-efficacy, by comparing the inter-
vention group to the control group regarding the change
from baseline to the 12-month follow-up. We used gene-
ralized linear models with identity function for the above
analyses.22 Similar to the primary analysis, we used
generalized estimating equations to account for the correla-
tion due to repeated measurement, and the model also
included the group indicator, the time indicator, and their
interaction. The regression coefficient corresponding to the
group-by-time interaction term estimates the difference
in mean change over time between the two study group
populations and, therefore, represents the intervention effect
on these secondary outcomes. We also evaluated how the
change in secondary outcomes impacted the change in
primary outcome via linear regression analysis. We reported
each of the regression coefficients (beta) of interest (i.e., the
beta for the interaction terms for assessment of the
intervention effect on the primary and secondary outcomes
and the beta for the change in secondary outcomes while
evaluating their impact on change of primary outcome),
as well as its corresponding p-value. Findings with a p-value
p 0.05 were considered statistically significant. The data
were cleaned and processed in SPSS version 20 and the
regression models were run in SAS version 9.3.
Ethics statement
The institutional review boards of all involved institutions
and the Brazilian Ministry of Health approved all study
procedures and consent forms. A U.S. Performance and
Safety Monitoring Board monitored the progress and
safety of the study, and no adverse events were reported.
Results
Participants and disposition
A total of 3,811 individuals were screened for inclusion,
of whom 464 were eligible for the study, agreed to
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participate, and underwent 1:1 randomized treatment assign-
ment (HIV Prevention vs. Health Promotion). Figure 2
describes participant recruitment. Twelve-month rates of
follow-up interviews were comparable in each study arm.
A total of 464 participants were randomized. The
demographic and clinical characteristics and HIV-risk
behaviors of the two intervention groups at baseline
did not differ statistically, indicating successful randomi-
zation (Table 1). Table 1 also includes 12-month post-
intervention follow-up and HIV testing information for both
groups.
Intervention adherence
Attendance at the main and booster intervention sessions
did not differ significantly between the groups (Table 1).
Only two participants attended zero sessions, for an
attrition rate of less than 1%. This was accomplished by
randomizing only participants who came to a brief orien-
tation session prior to the first session of each intervention.
Of eight intervention sessions, the mean (SD) number
attended was 5.5(62.4) or 68.8%, which compares favo-
rably with prior studies.4 Twenty-six percent of the partici-
pants attended all eight sessions, whereas 62.1% of the
participants attended six sessions or more; 10% attended
only one session. Of the three booster sessions, the mean
(SD) number attended was 1.5(61.3) or 50%. About one-
third (34.7%) of the participants did not come to any booster
sessions; 30.8% attended all three booster sessions.
Main outcomes
Although the magnitude of unprotected sex occasion
reduction was greater in the intervention group, the
Figure 2 Flow of study participants.
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Table 1 Sample demographics, baseline and 12-month follow-up characteristics and intervention adherence
Total sample (n=464) HIV (n=233) Health (n=231) Sig.*
Age, mean (SD) 43.3 (10.1) 43.5 (10.5) 43.2 (9.7) 0.746
Gender
Male 44.0 44.2 43.7 0.991
Female 56.0 55.8 56.3
Orientation
Heterosexual 92.8 93.5 92.1 0.699
Homosexual or bisexual 7.2 6.5 7.9
Race/ethnicityw
Black (negro) 20.3 17.6 22.9 0.516
White (branco) 32.3 34.3 30.3
Brown (pardo) 36.6 37.3 35.9
Other 10.8 10.7 10.8
Marital status
Single 34.7 32.6 36.8 0.765
Married/long-term relationship 46.1 48.1 44.2
Separated/divorced/widowed 18.5 18.9 18.2
Education completed
o Grade school 29.7 31.3 28.1 0.303
Grade school 12.1 12.4 11.7
High school incomplete 15.7 13.7 17.7
High school complete 24.4 27.0 21.6
Beyond high school 18.1 15.5 20.8
Diagnosis/symptoms
Schizophrenia 35.3 35.6 35.1 0.676
Bipolar disorder 21.1 20.2 22.1
Major depression with psychosis 9.3 9.9 8.7
Schizoaffective disorder/psychosis not otherwise specified 6.7 6.4 6.9
Common mental disorders 27.6 27.9 27.3
Comorbid substance use disorder 1.9 0.9 3.0
HIV-relevant history
HIV test (lifetime) 62.5 59.2 66.1 0.153
HIV+ 1.3 0.9 1.7 0.405
HIV-risk behaviors
Consistent condom use (every time)
Baseline 26.7 28.0 25.3 0.514
12-month follow-up 35.3 38.0 32.5 0.303
Unprotected vaginal/anal sex occasions, mean (SD)
Baseline 12.5 (24.6) 11.4 (26.2) 13.5 (23.0) 0.367
12-month follow-up 10.5 (23.6) 9.1 (19.9) 12.0 (26.9) 0.212
Number of sexual partners, mean (SD)
Baseline 1.4 (1.3) 1.3 (0.8) 1.5 (1.6) 0.063
12-month follow-up 1.0 (0.9) 1.0 (0.7) 1.0 (1.1) 0.463
HIV+ sexual partner
Baseline 1.9 2.1 1.7 0.746
12-month follow-up 0.5 0.5 0.5 0.981
Used alcohol/drugs before sex
Baseline 21.0 19.4 22.7 0.383
12-month follow-up 17.8 15.7 20.0 0.306
Intervention attendance (dose adherence)
Eight main intervention sessions, mean (SD) 5.5 (2.4) 5.5 (2.3) 5.5 (2.5) 1.00
Three booster sessions, mean (SD) 1.5 (1.3) 1.5 (1.3) 1.5 (1.2) 1.00
Data presented as %, unless otherwise specified.
HIV = human immunodeficiency virus; SD = standard deviation.
* t-statistic for continuous variables, chi-square statistic for categorical and ordinal variables.
wRace/ethnicity categories typically used in Brazilian studies.
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intent-to-treat analysis showed no statistically significant
differences between intervention groups from baseline
to the 12-month follow-up assessment (beta = -0.12,
p = 0.65) (Figure 3).
Thus, our primary null hypothesis was retained: sexual
risk behaviors in the intervention group were not sig-
nificantly reduced compared to the control group. Both
groups reported reductions in the number of vaginal and
anal intercourse occasions unprotected by condoms from
baseline to the 12-month follow-up assessment.
Secondary outcomes: Information-Motivation-Behavioral
Skills
Major secondary outcomes related to the IMB model
demonstrated that, compared to the control group, parti-
cipants in the HIV Prevention group had significantly
greater improvement in all IMB model domains from
baseline to the 12-month follow-up (Table 2), including
HIV knowledge (beta = 0.80, p o 0.001), motivation for
safer sex (beta = 0.25, p o 0.01), HIV behavioral inten-
tions (beta = 0.50, p o 0.001), and HIV prevention
behavioral skills (beta = 0.30, p o 0.001). Further,
regardless of the intervention arm, change in HIV
behavioral intentions from baseline to the 12-month
follow-up was associated with significantly fewer unpro-
tected sex occasions (beta = -7.45, p o 0.001) in all
participants (Figure 4).
Discussion
This paper reports on the outcome of a decade of NIMH-
funded research to adapt efficacious U.S. interventions
to reduce HIV risk behaviors among psychiatric patients
Figure 3 Comparison of mean number of unprotected sex occasions for both intervention conditions over all timepoints. HIV =
human immunodeficiency virus.
Table 2 Comparisons of intervention to control participants in improvement from baseline to the 12-month follow-up
assessment for major secondary outcomes
Control Intervention
Major secondary outcome Baseline* 12-month follow-up* Baseline* 12-month follow-up* p-valuew
Information
HIV knowledge 12.10 13.17 12.14 13.91 o 0.001
Motivation
HIV Behavioral Intentions 1.98 2.10 1.98 2.39 o 0.01
Personal Access to Condoms 0.79 0.97 0.76 1.43 o 0.001
Condom Attitude 1.83 1.87 1.74 2.11 o 0.001
Behavioral skills
Self-efficacy 1.60 1.70 1.59 1.96 o 0.001
HIV = human immunodeficiency virus.
*The numerical value showed the model predicted mean for each group at each of the timepoints. The statistical model included the group
indicator (intervention vs. control), the time indicator (12-month follow-up vs. baseline), and their interactions.
wThe p-values were used to test whether the group-by-time interaction equals zero. Any p-value o 0.05 indicated that there existed a
significant difference (between the intervention and control) in mean change over time (i.e., from baseline to the 12-month follow-up) of the
corresponding major secondary outcome.
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attending public mental health settings in Brazil, a country
where such interventions had not yet been tested. To our
knowledge, this is the only randomized, clinic-provider-
facilitated, HIV prevention efficacy trial to have been con-
ducted in a public system of outpatient care for adults with
mental illness. Consistent with NIMH-supported studies,
we identified the most appropriate and effective evidence-
based interventions for the target population; maintained
fidelity to their core elements; conducted systematic
assessments of the target population’s current risk factors,
behavioral determinants, and risk behaviors; and focused
on agency capacity, the potential for collaborations with
other partners, the need for cultural proficiency, and
evaluation of outcomes with rigorous efficacy testing.
This HIV trial suggests that, even in lower-resourced
public systems of care, clinicians can implement inter-
ventions designed to reduce the likelihood of high-risk
sexual behavior among their adult patients with mental
illness. However, we did not demonstrate intervention
efficacy. Despite the methodical rigor of 4 years of
formative preparatory work, successful randomization,
a collaborative community partnership, and evidence
that the intervention model had the intended effect on
the intervention group, unprotected sex occasions were
reduced in both intervention conditions by similar deg-
rees. It is of note that asking patients detailed questions
about their sex lives did not result in increased risk
behavior, as has often been feared, and it might be
speculated that repeatedly asking detailed questions about
sex and risk might have contributed to risk-reduction in
both intervention groups, either through real reductions or
the Hawthorne effect. The psychometric properties of the
SERBAS argue for the former, although we cannot be
certain that self-reported behavior reflects actual behavior.
Secondary outcomes demonstrated that the carefully
adapted HIV Prevention intervention resulted in signifi-
cantly greater improvements in all IMB model domains,
indicating that people with mental illness acquired the
skills and self-efficacy taught in this model. Moreover, one
of the model’s components, behavioral intentions, was
associated with fewer unprotected sex occasions across
intervention conditions, demonstrating that focusing on
behavioral intentions may be a productive pathway toward
reduced sexual risk behavior, which suggests promise for
applying the IMB model in future interventions.
The gap between successful application of a model and
the ability to demonstrate real-world efficacy or ‘‘effec-
tiveness’’ is an important dimension of this study. Several
decision points likely contributed to this gap and highlight
the most important limitations of our study. First, the patients
in our intervention had unexpectedly low rates of HIV risk
behavior compared to sexually active patients in our local
formative and pilot work, where 78% reported unprotected
vaginal or anal intercourse in the past 3 months,15 and to a
national multicenter sample of adults with mental illness
in Brazil (n=2,475), which similarly found a prevalence of
lifetime unprotected sex of 80.3%.26 Based on this finding,
our community partners urged us not to exclude individuals
who were sexually active in the prior 3 months, but had no
risk behavior at baseline, believing that sexual risk activity
would fluctuate due to psychiatric symptoms and unstable
living circumstances, and that the intervention would help
people maintain safer behaviors and/or help them develop
new or improved skills (e.g., condom negotiation). While this
approach seemed compelling at the time, a much larger
proportion (56.4%) of the RCT participants were not risky at
baseline (i.e., 100% condom use) compared to 22.2%
in the pilot, which compromised our ability to reach the
Figure 4 Information-Motivation-Behavioral model mediation of unprotected sex. HIV = human immunodeficiency virus; IMB =
Information-Motivation-Behavioral Skills. * p o 0.001, w p o 0.01.
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most at-risk patients and demonstrate intervention efficacy
or ‘‘effectiveness’’. Future studies should involve careful
ongoing monitoring practices to ensure that risk levels are
commensurate with the need for an intervention and to
adjust sampling appropriately.
Contamination may have played a role in between-
group risk-reduction similarities, given that we conducted
4 years of formative work at a clinic in the same city as our
RCT sites and also organized two well-attended city-wide
dissemination conferences. Unmeasured potential con-
tamination effects could have included changes in staff
practices, such as an increased focus on the risk of HIV
infection among patients both before and during the RCT.
Evidence suggestive of this influence includes the obser-
vation that patients in the pilot clinic already had a high
rate (54.1%) of lifetime HIV testing relative to the rate of
lifetime HIV testing among psychiatric patients in Brazil
nationwide, which hovers around 27%, and in Rio de
Janeiro, which is 19%.27,28 Participants in the RCT had an
even higher rate (62%) of lifetime HIV testing. Based on
our experience, we would urge future studies to employ
rapid ethnographic formative work to inform intervention
development in order to reduce contamination. In addi-
tion, we also recommend using a cluster RCT design to
randomly select clinics so that all patients in one site
would get either the active or the control intervention.
Though our statistical tests forced us to conclude that
our intervention did not significantly reduce sexual risk
behavior, in spite of significant changes in the IMB model
domains, the HIV intervention could have been tested to
ascertain its benefits for reducing sexual risk in real-world
care settings relative to standard care or brief individual-
level educational interventions, which are the types of HIV
prevention services most commonly found in psychiatric
care settings.29 While we can accelerate research by
implementing successful interventions without repeating
an efficacy component, there’s also a risk that an inter-
vention that proved to be effective in one setting will not
work as well in another setting. We offered an intensive
Health Promotion intervention that included a brief HIV
information component. The state-of-the-science required
establishment of efficacy against an attention-control (same
dose) intervention instead of effectiveness against treatment
as usual before taking even a rigorously adapted interven-
tion into the public psychiatric system in Brazil. More and
better guidance is needed to inform the adaptation and
testing of evidence-based practices to new settings.
Our results also highlight the tension between an inter-
vention’s effectiveness and its implementation. Accom-
modations to community preferences and priorities were
made to increase the likelihood that this intervention
would be successfully implemented at the study sites. In
fact, although the study was not designed to evaluate the
implementation of the intervention, we did collect informa-
tion on implementation processes and outcomes that
corresponded with the widely used Reach, Effectiveness,
Adoption, Implementation and Maintenance (RE-AIM)
framework.30 Reach was assessed by the percent and
representativeness of study participants. The number
of participants enrolled in the clinical trial exceeded
expectations, representing 65% of the eligible patients.
‘‘Effectiveness’’ (or efficacy) was assessed by the primary
and secondary outcomes described above. Although the
intervention was not effective in its primary outcome, it
did achieve secondary outcomes. Further, the adapted
intervention was used with fidelity by clinic providers; for
both intervention conditions, adherence to the manual
and competence of delivery were rated as ‘‘well done’’ or
‘‘very well done’’ more than 90% of the time. Adoption
was assessed by the percentage and representativeness
of participating settings and staff: 100% of providers
recruited to participate in the study agreed to do so and
underwent intervention training. Implementation was
assessed in terms of the consistency or fidelity of deli-
vering the intervention and adaptations made to it, and
maintenance was assessed by the long-term effects on
individual and setting levels. Maintenance could not be
assessed even though both clinics and clinic providers
wanted to continue the intervention upon conclusion of
the study; however, a priori consensus prevented the
clinics from doing so. While the trial did achieve the RE-
AIM outcomes of reach, adoption, implementation, and
potential maintenance, it failed to achieve the outcome
of efficacy or ‘‘effectiveness.’’ Just as the interventions
themselves are subject to compromise between adapta-
tion and fidelity, research designs to evaluate effective-
ness and implementation outcomes may require similar
compromises, perhaps by adopting rigorous alternatives
to the traditional RCT.31
Implementation science has been the focus of research
only in the last decade, after the scientific community
became aware of the important research-to-practice gap,
where few health innovations, especially mental health
and behavioral interventions, made it through the efficacy,
effectiveness, and implementation pathway.32 We hope
that lessons learned from our 10 intensive years of
rigorous research will help future investigators conduct
implementation studies in real-world settings, especially
when those studies use community-based participatory
research. Considerable attention will be needed during
implementation trials to determine how best to balance
scientific rigor with community input to make sustainable
practice changes.
Acknowledgements
This research was supported by grant R01 MH65163
(MLW) from the United States NIMH and a center grant
from the United States NIMH to the HIV Center for Clinical
and Behavioral Studies at NY State Psychiatric Institute
and Columbia University (P30-MH43520; principal inves-
tigator: Anke A. Ehrhardt). The authors gratefully acknow-
ledge the enormous contributions made to the PRISSMA
Project by people receiving care at Instituto de Psiquiatria
(IPUB), Universidade Federal do Rio de Janeiro (UFRJ),
Instituto Municipal Philippe Pinel (IMPP), Centro Psiquiá-
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Silva Ramos, Ângelo Amado, Ariadna Patrı́cia Estevez,
Bianca Ramos, Bibiana Caccavo Machado, Carlos Lin-
hares Veloso Filho, Carolina Xavier, Claudia Simone dos
Santos Oliveira, Cristiane Borges, Daniel Osório, Deborah
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